share_log

4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Dogan Meeshanthini

SEC ·  Oct 8, 2024 22:46

Summary by Futu AI

On September 6, 2024, Meeshanthini Dogan, the Chief Executive Officer of Cardio Diagnostics Holdings, Inc. [CDIO], completed a purchase of company stock. The transaction involved the acquisition of 68,965 shares of common stock at a price of $0.29 per share. Following this transaction, Dogan's direct holdings in the company increased to a total of 1,655,429 shares. The purchase, conducted on the open market, reflects the CEO's direct investment in the company's stock and is a matter of record for investors monitoring insider activity.
On September 6, 2024, Meeshanthini Dogan, the Chief Executive Officer of Cardio Diagnostics Holdings, Inc. [CDIO], completed a purchase of company stock. The transaction involved the acquisition of 68,965 shares of common stock at a price of $0.29 per share. Following this transaction, Dogan's direct holdings in the company increased to a total of 1,655,429 shares. The purchase, conducted on the open market, reflects the CEO's direct investment in the company's stock and is a matter of record for investors monitoring insider activity.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.